Shanghai Aohua Photoelectricity Endoscope Co., Ltd.

SHSE:688212 Stock Report

Market Cap: CN¥7.1b

Shanghai Aohua Photoelectricity Endoscope Past Earnings Performance

Past criteria checks 4/6

Shanghai Aohua Photoelectricity Endoscope has been growing earnings at an average annual rate of 16.5%, while the Medical Equipment industry saw earnings growing at 14.5% annually. Revenues have been growing at an average rate of 23.1% per year. Shanghai Aohua Photoelectricity Endoscope's return on equity is 4.4%, and it has net margins of 8.5%.

Key information

16.5%

Earnings growth rate

-11.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate23.1%
Return on equity4.4%
Net Margin8.5%
Next Earnings Update30 Apr 2024

Recent past performance updates

We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings

Apr 16
We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings

Recent updates

We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings

Apr 16
We Think That There Are Issues Underlying Shanghai Aohua Photoelectricity Endoscope's (SHSE:688212) Earnings

Here's Why Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Has Caught The Eye Of Investors

Mar 17
Here's Why Shanghai Aohua Photoelectricity Endoscope (SHSE:688212) Has Caught The Eye Of Investors

Revenue & Expenses Breakdown
Beta

How Shanghai Aohua Photoelectricity Endoscope makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688212 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2367858289147
30 Sep 2359358272143
30 Jun 2356755242129
31 Mar 2348935217114
31 Dec 224452219897
30 Sep 223994517774
30 Jun 223685315363
31 Mar 223575114453
31 Dec 213475713449
30 Sep 213416711244
30 Jun 213174511743
31 Mar 212883710940
31 Dec 202631910539
31 Dec 192985310330
31 Dec 18156-67221
31 Dec 17130-45915

Quality Earnings: 688212 has a high level of non-cash earnings.

Growing Profit Margin: 688212's current net profit margins (8.5%) are higher than last year (4.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688212 has become profitable over the past 5 years, growing earnings by 16.5% per year.

Accelerating Growth: 688212's earnings growth over the past year (167%) exceeds its 5-year average (16.5% per year).

Earnings vs Industry: 688212 earnings growth over the past year (167%) exceeded the Medical Equipment industry 1.2%.


Return on Equity

High ROE: 688212's Return on Equity (4.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.